ELV's Quality Score fell 2 points on Fri, Oct 30, to 7.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Down 1% over three years while the S&P 500 rose 92%; up 28% in the past year.
2 more reasons why ELV lags the market, from its filings, with the other side, the timeline, and its peers, for Pro members.
| The chart | Above a rising 200-day average |
| Latest filing | 8-K, Oct 21 |
4 more reasons behind ELV's 7, for Pro members.
Fri Dec 4: Ex-dividend, $1.72 a shareAt the open. Pays Dec 18.
After its last 4 reports it closed -1.0% on average, higher 2 of 4 times.
AverageTransition, 2 of 14 chart checks firingWhat the Quality Score means
Well below its recent run. ELV scores 7 today, against a median of 11 over its last 20 recorded sessions.
ELV is #7 of 10 by Quality Score among Hospital & Medical Service Plans.
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| 7 |
Net income over four quarters: ELV $4.96B, UNH $14.1B, CI $6.23B, MOH -$7.00M.
Expected to report Thu Jan 28, before the open (in 90 days). Expected.
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
Sales of $50.4B, 1% more than a year ago; a profit of $6.27 a share, from $5.32.
“This was driven by higher premium yields, increased CarelonRx product revenue, and growth in service fees, partially offset by lower Medicare Advantage, Medicaid, and Employer Group risk membership.”
ELV's results filing gives no sales by line in a table we read.
| Measure | Figure |
|---|---|
| Diluted EPS | at least $22.00 |
“The benefit expense ratio of 90.6 percent improved 70 basis points, driven by better performance in Medicare Advantage and Individual ACA compared to the prior year.”
From its results filing (SEC filing · Oct 21)
Sales grew 10% a year over 5 years, fiscal 2020 to 2025.
Pays $6.88 a share a year.
| Reported | Gap | Reaction | 5 sessions |
|---|---|---|---|
| Oct 21, 2026 | +1.1% | -1.4% | -4.3% |
| Jul 15, 2026 | -8.0% | -8.5% | -7.8% |
| Apr 22, 2026 | +3.0% | +0.0% | +10.6% |
Sales grew every year from 2018 to 2025, to $199B. It made a profit in each of the eight years.
Its dividends come to 24% of its free cash flow.
| Dividend | $6.88 a share a year |
| Paid out | About $1.5B a year |
| Free cash flow | $6.3B |
| Record | Raised each of the last 4 years |
2 insiders bought $1.4M across 3 filings, and 3 insiders sold $5.5M across 16 filings, in the last 6 months. The newest:
8 trades disclosed in the last six months. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: ELV is 0.4% of VIG, 0.4% of VYM, and 0.3% of DGRO, the most of the 24 funds Breakaway covers, by their holdings as filed for Jul 31, 2026.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
“The managed care industry is highly competitive, both nationally and in our local markets.”
ELV scores 7 today, which Breakaway calls Average. It is #7 of 10 in Hospital & Medical Service Plans by Quality Score, with 2 of 14 chart checks firing. Down 1% over three years while the S&P 500 rose 92%; up 28% in the past year. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
ELV scores 7 today, which Breakaway calls Average (6 to 10). That is #7 of 10 in Hospital & Medical Service Plans by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind ELV's 7.
2 insiders bought $1.4M across 3 filings, and 3 insiders sold $5.5M across 16 filings, in the last 6 months. The newest is Mark Kaye, EVP & CFO, who sold $1M on Oct 22. Every filing, with the scored weight, for Pro members.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.